> Details

Michaelsen, Jochen; Parade, Ulli; Bauerle, Hansjoerg; Winter, Klaus-Dieter; Rauschenbach, Ulrich; Mischke, Karl; Schaefer, Carl; Gutleben, Klaus-Juergen; Willich, Tobias; Breithardt, Ole-Alexander A; Middendorf, Stefan; Grove, Rainer; Mosa, Joerg; Krug, Joachim; Hoffmann, Rainer

Abstract 11445: Safety and Efficacy of Cryoballoon Ablation for Atrial Fibrillation Performed at Community Hospitals with Low to Medium Case Numbers: Acute and First Long Term Results of The German "Regional" Registry

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Abstract 11445: Safety and Efficacy of Cryoballoon Ablation for Atrial Fibrillation Performed at Community Hospitals with Low to Medium Case Numbers: Acute and First Long Term Results of The German "Regional" Registry
  • Contributor: Michaelsen, Jochen; Parade, Ulli; Bauerle, Hansjoerg; Winter, Klaus-Dieter; Rauschenbach, Ulrich; Mischke, Karl; Schaefer, Carl; Gutleben, Klaus-Juergen; Willich, Tobias; Breithardt, Ole-Alexander A; Middendorf, Stefan; Grove, Rainer; Mosa, Joerg; Krug, Joachim; Hoffmann, Rainer
  • Published: Ovid Technologies (Wolters Kluwer Health), 2021
  • Published in: Circulation, 144 (2021) Suppl_1
  • Language: English
  • DOI: 10.1161/circ.144.suppl_1.11445
  • ISSN: 0009-7322; 1524-4539
  • Origination:
  • Footnote:
  • Description: Introduction: Pulmonary vein isolation (PVI) using cryoballoon ablation (CBA) is a guideline recommended treatment for symptomatic paroxysmal and persistent atrial fibrillation. Little is known on performance data of CBA in low to medium volume hospitals. Hypothesis: To determine safety and efficacy of PVI using CBA performed at community hospitals with limited annual case numbers. Methods: This prospective registry included 1004 consecutive patients (pts) who had CBA performed for symptomatic paroxysmal (n=563) or persistent AF (n=441) at 20 hospitals, each with <100 PVI / year. CBA procedures were performed according to local standards. Procedural data, efficacy and complication rates were determined. Results: The mean number of CBA / year / center was 59±25. CBA was performed by a total of 22 operators (1.1/center), 12/20 operators were board certified for invasive electrophysiology. Average procedure time was 90.1±31.6 min, fluoroscopy time was 19.2±11.4 min. Isolation of all pulmonary veins was reached in 97.9% of pts, the most frequent reason for not achieving complete isolation was development of phrenic nerve palsy (PNP). No hospital deaths were observed. 2 pts (0.2%) suffered a clinical stroke. Pericardial effusion occurred in 6 pts (0.6%), 2 (0.2%) required pericardial drainage. Vascular complications occurred in 24 pts (2.4%), 2 pts (0.2%) underwent vascular surgery. PNP occurred in 48 pts (4.8%) and persisted up to discharge in 6 pts (0.6%). The results were independant for board certification status of the operator and independant for the number of enrolled patients per center (if > or < 60 pts). Follow up data at 12 months were available from 14 centers and 75,2 % of their pts so far. Recurrent atrial arrhythmias after a 3 months blanking period were found in 177/536 pts. (33%), 152 (85,9%) were symptomatic. 71 (40%) pts with recurrence were still on antiarrhythmic drugs, 42 (23.7%) underwent Re-PVI. One phrenic nerve palsy persisted, there were no further access site complications and no esophago-atrial fistula. Conclusions: PVI for paroxysmal or persistant AF using CBA can be safely performed at community hospitals with high acute efficacy, low complication rates and good recurrence data after 1 year despite low and moderate annual case numbers.
  • Access State: Open Access